Search Results - "BIRKHOFER, M. J"

Phase II and pharmacokinetic study of paclitaxel therapy for unresectable hepatocellular carcinoma patients by CHAO, Y, CHAN, W.-K, LEE, S.-D, BIRKHOFER, M. J, HU, O. Y.-P, WANG, S.-S, HUANG, Y.-S, LIU, M, WHANG-PENG, J, CHI, K.-H, LUI, W.-Y

“…Hepatocellular carcinoma (HCC) is a common lethal disease in Asia and there is no effective chemotherapy. Identification of new effective drugs in the…”
Get full text

Phase I and pharmacologic study of the combination paclitaxel and carboplatin as first-line chemotherapy in stage III and IV ovarian cancer by Huizing, M T, van Warmerdam, L J, Rosing, H, Schaefers, M C, Lai, A, Helmerhorst, T J, Veenhof, C H, Birkhofer, M J, Rodenhuis, S, Beijnen, J H, ten Bokkel Huinink, W W

“…To determine the maximum-tolerated dose for the combination paclitaxel and carboplatin administered every 4 weeks and to gain more insight into the…”
Get more information

A Dose-Escalation Study of the Safety, Tolerability, and Pharmacokinetics of Intravenous Gatifloxacin in Healthy Adult Men by Gajjar, Diptee A., LaCreta, Frank P., Uderman, Howard D., Kollia, Georgia D., Duncan, Glenn, Birkhofer, Martin J., Grasela, Dennis M.

“…Study Objectives. To examine single‐ and multiple‐dose safety, tolerability and pharmacokinetics of gatifloxacin administered as daily 1‐hour intravenous…”
Get full text

CTLA4Ig-mediated blockade of T-cell costimulation in patients with psoriasis vulgaris by Abrams, J R, Lebwohl, M G, Guzzo, C A, Jegasothy, B V, Goldfarb, M T, Goffe, B S, Menter, A, Lowe, N J, Krueger, G, Brown, M J, Weiner, R S, Birkhofer, M J, Warner, G L, Berry, K K, Linsley, P S, Krueger, J G, Ochs, H D, Kelley, S L, Kang, S

“…Engagement of the B7 family of molecules on antigen-presenting cells with their T cell-associated ligands, CD28 and CD152 (cytotoxic T lymphocyte-associated…”
Get full text

Bioavailability and phase II study of oral UFT plus leucovorin in patients with relapsed or refractory colorectal cancer by MEROPOL, N. J, SONNICHSEN, D. S, BIRKHOFER, M. J, FERREIRA, I, NOEL, D

“…This study was undertaken to address the influence of concurrent administration on the pharmacokinetics of UFT (uracil plus tegafur) and leucovorin (LV), and…”
Get full text

A dose-escalation study of the safety, tolerability, and pharmacokinetics of intravenous gatifloxacin in healthy adult men: Pharmacokinetics of gatifloxacin: dosing considerations and use in special populations by GAJJAR, D. A, LACRETA, F. P, UDERMAN, H. D, KOLLIA, G. D, DUNCAN, G, BIRKHOFER, M. J, GRASELA, D. M

Get full text

Oral UFT plus leucovorin in patients with relapsed or refractory colorectal cancer by Meropol, N J, Noel, D, Sonnichsen, D S, Birkhofer, M J

“…Therapeutic options for patients with advanced colorectal cancer who have failed treatment with fluorouracil (5-FU) are limited. Responses have been reported…”
Get more information

Bioavailability and phase II study of oral UFT plus leucovorin in patients with relapsed or refractory colorectal cancer by Meropol, Neal, Sonnichsen, Daryl, Birkhofer, Martin, Ferreira, Irene, Noel, Diane

Get full text